# Alpha-Lipoic Acid in Patients With Sepsis

> **NCT05808946** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 60 (estimated)

## Conditions studied

- Sepsis

## Interventions

- **DRUG:** Alpha-Lipoic Acid
- **DRUG:** Sepsis Supportive Care

## Key facts

- **NCT ID:** NCT05808946
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-10
- **Primary completion:** 2024-10
- **Final completion:** 2024-10
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05808946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05808946, "Alpha-Lipoic Acid in Patients With Sepsis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05808946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*